Company Filing History:
3 out of 1,745 
3 out of 23 
2 out of 141 
Years Active: 2020-2024
Title: Severine Bezie: Pioneering Innovations in Regulatory T Cell Research
Introduction
Severine Bezie, based in Nantes, France, is an accomplished inventor with a significant impact in the field of immunology. With three patents to her name, she has contributed to innovative methods for obtaining regulatory T cells, showcasing her dedication to advancing medical research.
Latest Patents
Severine's latest patents focus on methodologies for obtaining regulatory T cells, particularly involving interleukin-34 (IL-34) polypeptides. These patents detail a process that includes culturing human monocytes to generate immunosuppressive macrophages and subsequently co-culturing these macrophages with human peripheral blood mononuclear cells (PBMCs). This innovative approach opens new avenues for therapeutic applications in immunology.
Career Highlights
During her career, Severine has collaborated with prominent institutions such as the Centre Hospitalier Universitaire de Nantes and Inserm (Institut National de la Santé et de la Recherche Médicale). Her work in these esteemed organizations has allowed her to delve deeper into the mechanisms of immune responses and develop novel therapeutic strategies.
Collaborations
Throughout her professional journey, Severine Bezie has had the opportunity to collaborate with notable colleagues, including Carole Guillonneau and Ignacio Anegon. These collaborations have enhanced her research and contributed to the successful outcomes of her innovative projects in the realm of immunology.
Conclusion
Severine Bezie's contributions to the field of regulatory T cell research underscore her status as a leading inventor. With her patented methodologies and collaborative spirit, she continues to pave the way for advancements in immunological therapies, ultimately benefiting the broader medical community.